In continuing coverage, Medscape (3/15, Brauser) reports that psychiatrists are at the top of ProPublica’s “updated Dollars for Docs list of large payments from pharmaceutical companies to individual US clinicians,” released March 12. Medscape Medical News spoke with James Scully, MD, CEO of the American Psychiatric Association, who said, “It surprises me because we’ve made so many changes in what we’ve done here at the APA.” He added, “Clearly, however, there are others out there who are still working closely with industry. That’s perfectly legal. But it’s important to have open communication. If people want to do marketing for drug companies, they need to be clear that that’s what they’re doing.”
